Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
Cancer Prevention Research (Philadelphia, Pa.)|March 2, 2021
Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic NeoplasiaFrank A Sinicrope, Thomas R Viggiano, Navtej S Buttar, et al.Cancer Prevention Research (Philadelphia, Pa.)|May 4, 2026
Randomized, Double-blind, Placebo-controlled Trial of Meriva® (curcuminoids) as a Candidate Chemoprevention Agent for Gastric CarcinogenesisMaria Gonzalez-Pons, Ricardo L Dominguez, Eleazar E Montalvan-Sanchez, et al.Journal of the National Cancer Institute|February 19, 2004
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instabilityAsad Umar, C Richard Boland, Jonathan P Terdiman, et al.Cancer Prevention Research (Philadelphia, Pa.)|September 6, 2019
Efficacy of Difluoromethylornithine and Aspirin for Treatment of Adenomas and Aberrant Crypt Foci in Patients with Prior Advanced Colorectal NeoplasmsFrank A Sinicrope, Pruthvi R Velamala, Louis M Wong Kee Song, et al.JAMA Oncology|December 5, 2024
Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020Katrina A B Goddard, Eric J Feuer, Jeanne S Mandelblatt, et al.Gastroenterology|July 5, 2021
Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse ModelJohannes Gebert, Ozkan Gelincik, Mine Oezcan-Wahlbrink, et al.JAMA Oncology|January 29, 2026
Cancer Incidence and Mortality With Aspirin in Older Adults: Follow-Up of the ASPREE TrialSuzanne G Orchard, Galina Polekhina, John Zalcberg, et al.Journal of the National Cancer Institute|August 12, 2020
Effect of Aspirin on Cancer Incidence and Mortality in Older AdultsJohn J McNeil, Peter Gibbs, Suzanne G Orchard, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2023
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal AdenomaRobert E Schoen, Lisa A Boardman, Marcia Cruz-Correa, et al.Nature Medicine|January 16, 2026
Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trialAnna Morena D'Alise, Jason Willis, Fahriye Duzagac, et al.Pageof 8